Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
FR0004056851
Fri, 12.04.2024
Valneva
First Berlin Equity Research has published a research update on Valneva SE
(ISIN: FR0004056851). Analyst Simon Scholes reiterated his BUY rating and
maintained his EUR 8.60 price target.
Abstract:
The final 2023 results release package provided upward guidance revisions
and improved medium-term visibility in several key areas. In addition,
Valn [ … ]
Tue, 27.02.2024
Valneva
First Berlin Equity Research has published a research update on Valneva SE
(ISIN: FR0004056851). Analyst Simon Scholes reiterated his BUY rating and
decreased the price target from EUR 8.90 to EUR 8.60.
Abstract:
FY/23 product revenues recovered strongly (+26% to €144.6m) in line with
resurgent travel activity. The current cash position is [ … ]
Thu, 12.10.2023
Valneva
First Berlin Equity Research has published a research update on Valneva SE
(ISIN: FR0004056851). Analyst Simon Scholes reiterated his BUY rating and
maintained his EUR 8.90 price target.
Abstract:
Both Q2/23 revenues and adjusted EBITDA were above our and consensus
forecasts and management has reiterated full-year product revenue guidance
of &e [ … ]
Mon, 22.05.2023
Valneva
First Berlin Equity Research has published a research update on Valneva SE
(ISIN: FR0004056851). Analyst Simon Scholes reiterated his BUY rating and
maintained his EUR 8.90 price target.
Abstract:
Valneva's Q1 results were close to our expectations. Product sales nearly
doubled to €32.1m driven by strongly recovering demand for the travel
v [ … ]
Mon, 22.05.2023
Valneva
First Berlin Equity Research has published a research update on Valneva SE
(ISIN: FR0004056851). Analyst Simon Scholes reiterated his BUY rating and
maintained his EUR 8.90 price target.
Abstract:
Valneva's Q1 results were close to our expectations. Product sales nearly
doubled to €32.1m driven by strongly recovering demand for the travel
v [ … ]
Tue, 04.04.2023
Valneva SE
First Berlin Equity Research has published a research update on Valneva SE
(ISIN: FR0004056851). Analyst Simon Scholes upgraded the stock to BUY but
decreased the price target from EUR 12.00 to EUR 8.90.
Abstract:
2023 guidance for revenue and other income of €220-260m is below the
equivalent 2022 figure of €373.5m. However, over &euro [ … ]
Tue, 04.04.2023
Valneva SE
First Berlin Equity Research has published a research update on Valneva SE
(ISIN: FR0004056851). Analyst Simon Scholes upgraded the stock to BUY but
decreased the price target from EUR 12.00 to EUR 8.90.
Abstract:
2023 guidance for revenue and other income of €220-260m is below the
equivalent 2022 figure of €373.5m. However, over &euro [ … ]
Fri, 19.08.2022
Valneva SE
First Berlin Equity Research hat ein Research Update zu Valneva SE (ISIN:
FR0004056851) veröffentlicht. Analyst Simon Scholes stuft die Aktie auf ADD
herab und senkt das Kursziel von EUR 12,50 auf EUR 12,00.
Zusammenfassung:
Das EBITDA des ersten Halbjahres 2022 lag aufgrund von Abschreibungen im
Zusammenhang mit der Reduzierung von COVID-1 [ … ]
Fri, 19.08.2022
Valneva SE
First Berlin Equity Research hat ein Research Update zu Valneva SE (ISIN:
FR0004056851) veröffentlicht. Analyst Simon Scholes stuft die Aktie auf ADD
herab und senkt das Kursziel von EUR 12,50 auf EUR 12,00.
Zusammenfassung:
Das EBITDA des ersten Halbjahres 2022 lag aufgrund von Abschreibungen im
Zusammenhang mit der Reduzierung von COVID-1 [ … ]
Tue, 26.07.2022
Valneva SE
First Berlin Equity Research hat ein Research Update zu Valneva SE (ISIN:
FR0004056851) veröffentlicht. Analyst Simon Scholes stuft die Aktie auf BUY
herauf und erhöht das Kursziel von EUR 12,00 auf EUR 12,50.
Zusammenfassung:
Letzte Woche gab Valneva bekannt, dass die EU-Mitgliedstaaten im Jahr 2022
1,25 Millionen Dosen des COVID-19-I [ … ]